论文信息 - Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection - 字舞流文

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

N. Enomoto | K. Chayama | T. Pilot‐Matias | A. Takaki | A. Ido | M. Burroughs | H. Toyoda | W. Xie | K. Ikeda | H. Kumada | R. Redman | Ken Sato | F. Suzuki | Koji Kato | R. Oberoi | D. Pugatch | Tsunamasa Watanabe | M. Atsukawa | P. Krishnan | K. Alves